Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

What a polarized U.S. might learn from other countries in 'Another World is Possible' March 20, 2025 • Journalist Natasha Hakimi Zapata's book "Another World is Possible" explores what the U.S ...

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

Dessert sushi has become the latest trend to take over social media as savvy home cooks have whipped up sweet versions of the Japanese dish using brownies, Oreos, fruit and chocolate. The trend ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Here’s your preview for anime coming to Netflix in 2025.